Effects of Pitavastatin on Monocyte, Endothelial Dysfunction and HDL-C in Subjects With Metabolic Syndrome
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine in detail the acute and chronic effects of
pitavastatin on plasma lipid transport and atheroma biomarkers in patients at elevated risk
for the premature development of atherosclerosis (CAPITAIN).